No black box warning on record for Serevent Diskus

As of the latest FDA labeling reviewed, Serevent Diskus (SALMETEROL XINAFOATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Serevent Diskus medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • LABA as monotherapy (without ICS) for asthma increase the risk of asthma-related death and asthma-related hospitalizations. Prescribe for asthma only as concomitant therapy with an inhaled corticosteroid. ( 5.1 ) • Do not initiate in acutely deteriorating asthma or COPD. Do not use to treat acute symptoms. ( 5.2 ) • Not a substitute for corticosteroids. Patients with a

No black box warning on record for Serevent Diskus

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • LABA as monotherapy (without ICS) for asthma increase the risk of asthma-related death and asthma-related hospitalizations. Prescribe for asthma only as concomitant therapy with an inhaled corticosteroid. ( 5.1 ) • Do not initiate in acutely deteriorating asthma or COPD. Do not use to treat acute symptoms. ( 5.2 ) • Not a substitute for corticosteroids. Patients with a

Serevent Diskus Black Box Warning

No black box warning on record for Serevent Diskus

Other warnings & precautions

Serevent Diskus Black Box Warning

No black box warning on record for Serevent Diskus

Other warnings & precautions